Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
23-я Всероссийская научно-практическая конференция с международным участием
Современные технологии лечения витреоретинальной патологии 2026
22-я Всероссийская научно-практическая конференция с международным участием
Современные технологии лечения витреоретинальной патологии 2025
23-я Всероссийская научно-практическая конференция с международным участием
Современные технологии лечения витреоретинальной патологии 2026
| Реферат RUS | Реферат ENG | Литература | Полный текст |
| УДК: | 617.735 DOI: https://doi.org/10.25276/0235-4160-2021-3-89-94 |
Козина Е.В., Сахнов С.Н., Мясникова В.В., Быкова Е.В.
Анализ клинических случаев A-VEGF-терапии пациентов с разрывами пигментного эпителия, осложняющими влажную возрастную макулодистрофию
Краснодарский филиал «НМИЦ МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова» Минздрава РФ
Кубанский государственный медицинский университет
1. Будзинская М.В. Возрастная макулярная дегенерация. Вестник офтальмологии. 2014;130(6): 56–61. [Budzinskaya MV. Age-related macular degeneration. The Russian Annals of Ophthalmology. 2014;130(6): 56–61. (In Russ.)].
2. Introini U, Gimeno AT, Fabrizio Scotti F, Setaccioli M, Giatsidis S, Bandello F. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefes Arch Clin Exp Ophthalmol. 2012;250: 1283–1292. doi:10.1007/s00417-012-1955-2
3. Ersoz MG, Karacorlu M, Arf S, Muslubas IS, Hocaoglu M. Retinal pigment epithelium tears: Classification, pathogenesis, predictors, and management. Surv Ophthalm. 2017;62: 493–505.
4. Mouallem A, Sarraf D, Chen X, Capuano V, Souied E, Querques G. Double retinal pigment epitheliumtears in neovascular age-relatedmacular degeneration. Retina. 2016;36(11): 2197–2204.
5. Christoph R, Nicole C. Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica. 2016;235: 1–9. doi: 10.1159/000439445
6. Leon P E, Saviano S, Zanei A, Pastore M R. Spontaneous or secondary to intravitreal injections of anti-angiogenic agents retinal pigment epithelial tears in age-related macular degeneration. J Ophtalmol. 2014;7(4): 681–685. doi: 10.3980/j.issn.2222-3959.2014.04.18.
7. Driscoll S, Sunir JG. Managing Submacular Hemorrhage. Review of ophthalmology. 2014;6(1).
8. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16: 183–189.
9. Cho HJ, Kim HS, Yoo SG, Han JI, Lew YJ, Cho SW, Lee TG, Kim JW. Retinal pigment epithelial tear after intravitreal ranibizumab treatment for neovascular age-related macular degeneration. Retina. 2016;36(10): 1851–1859.
10. Durkin SR, Farmer LD, Kulasekara S, Gilhotra J. Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2016;254(1): 1–6. doi: 10.1007/s00417-015-2978-2.
11. Shin JY, Choi M, Chung B, Byeon SH. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015;253(12): 2151–60. doi: 10.1007/s00417-015-2977-3.
12. Empeslidis T, Vardarinos A, Konidaris V, Ch'ng SW, Kapoor B, Deane J, Tsaousis KT. Incidence of retinal pigment epithelial tears and associated risk factors after treatment of age-related macular degeneration with Intravitreal Anti-VEGF injections. Open Ophthalmol J. 2014;31(8): 101–104. doi: 10.2174/1874364101408010101
13. Хайнрих Х., Кельнер У., Ферстер М. Атлас по ангиографии глазного дна. Под ред. Астахова Ю.С., Лисочкиной А.Б. М.: «МЕДпресс-информ»; 2008. [Heinrich H, Kelner U, Ferster M. Astakhov US, Lisochkina AB. (eds). Atlas of fundus angiography stuttgart. M.: «MEDpress-inform»; 2008. (In Russ.)]
14. Clemens CR, Eter N. Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica. 2016;235(1): 1–9.
15. Nagiel A, Freund KB, Spaide RF. Mechanism of retinal pigment epithelium tear formation following intravitreal Anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;56(5): 981–988.
16. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. A new grading system for retinal pigment epithelial tears. Retina. 2010; 30(7): 1039–1045.
17. Skaf AR, Mahmoud T. Surgical treatment of age-related macular degeneration. Seminars in Ophthalmology. 2011;26(3): 181–191.
18. Van Romunde SH, Polito A, Bertazzi L, Guerriero M, Pertile G. Long-term results of full macular translocation for choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2015;122(7): 1366–1374. doi: 10.1016/j.ophtha.2015.03.012
19. Invernizzi A, Nguyen V, Arnold J, Young S, Barthelmes D, Gillies M. Early and late retinal pigment epithelium tears after antievascular endothelial growth factor therapy for neovascular age-related macular degeneration. Trans Am Ophthalmol Soc. 2017;10(6): 2017–1189.
20. Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment. Trans Am Ophthalmol Soc. 2014;112: 142–59.
2. Introini U, Gimeno AT, Fabrizio Scotti F, Setaccioli M, Giatsidis S, Bandello F. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefes Arch Clin Exp Ophthalmol. 2012;250: 1283–1292. doi:10.1007/s00417-012-1955-2
3. Ersoz MG, Karacorlu M, Arf S, Muslubas IS, Hocaoglu M. Retinal pigment epithelium tears: Classification, pathogenesis, predictors, and management. Surv Ophthalm. 2017;62: 493–505.
4. Mouallem A, Sarraf D, Chen X, Capuano V, Souied E, Querques G. Double retinal pigment epitheliumtears in neovascular age-relatedmacular degeneration. Retina. 2016;36(11): 2197–2204.
5. Christoph R, Nicole C. Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica. 2016;235: 1–9. doi: 10.1159/000439445
6. Leon P E, Saviano S, Zanei A, Pastore M R. Spontaneous or secondary to intravitreal injections of anti-angiogenic agents retinal pigment epithelial tears in age-related macular degeneration. J Ophtalmol. 2014;7(4): 681–685. doi: 10.3980/j.issn.2222-3959.2014.04.18.
7. Driscoll S, Sunir JG. Managing Submacular Hemorrhage. Review of ophthalmology. 2014;6(1).
8. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16: 183–189.
9. Cho HJ, Kim HS, Yoo SG, Han JI, Lew YJ, Cho SW, Lee TG, Kim JW. Retinal pigment epithelial tear after intravitreal ranibizumab treatment for neovascular age-related macular degeneration. Retina. 2016;36(10): 1851–1859.
10. Durkin SR, Farmer LD, Kulasekara S, Gilhotra J. Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2016;254(1): 1–6. doi: 10.1007/s00417-015-2978-2.
11. Shin JY, Choi M, Chung B, Byeon SH. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015;253(12): 2151–60. doi: 10.1007/s00417-015-2977-3.
12. Empeslidis T, Vardarinos A, Konidaris V, Ch'ng SW, Kapoor B, Deane J, Tsaousis KT. Incidence of retinal pigment epithelial tears and associated risk factors after treatment of age-related macular degeneration with Intravitreal Anti-VEGF injections. Open Ophthalmol J. 2014;31(8): 101–104. doi: 10.2174/1874364101408010101
13. Хайнрих Х., Кельнер У., Ферстер М. Атлас по ангиографии глазного дна. Под ред. Астахова Ю.С., Лисочкиной А.Б. М.: «МЕДпресс-информ»; 2008. [Heinrich H, Kelner U, Ferster M. Astakhov US, Lisochkina AB. (eds). Atlas of fundus angiography stuttgart. M.: «MEDpress-inform»; 2008. (In Russ.)]
14. Clemens CR, Eter N. Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica. 2016;235(1): 1–9.
15. Nagiel A, Freund KB, Spaide RF. Mechanism of retinal pigment epithelium tear formation following intravitreal Anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;56(5): 981–988.
16. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. A new grading system for retinal pigment epithelial tears. Retina. 2010; 30(7): 1039–1045.
17. Skaf AR, Mahmoud T. Surgical treatment of age-related macular degeneration. Seminars in Ophthalmology. 2011;26(3): 181–191.
18. Van Romunde SH, Polito A, Bertazzi L, Guerriero M, Pertile G. Long-term results of full macular translocation for choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2015;122(7): 1366–1374. doi: 10.1016/j.ophtha.2015.03.012
19. Invernizzi A, Nguyen V, Arnold J, Young S, Barthelmes D, Gillies M. Early and late retinal pigment epithelium tears after antievascular endothelial growth factor therapy for neovascular age-related macular degeneration. Trans Am Ophthalmol Soc. 2017;10(6): 2017–1189.
20. Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment. Trans Am Ophthalmol Soc. 2014;112: 142–59.
Страница источника: 89-94
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн




















